Literature DB >> 17761781

Lack of association between common polymorphisms in UGT1A9 and gene expression and activity.

Jacqueline Ramírez1, Wanqing Liu, Snezana Mirkov, Apurva A Desai, Peixian Chen, Soma Das, Federico Innocenti, Mark J Ratain.   

Abstract

Interindividual variability in the glucuronidation of xenobiotics metabolized by UDP-glucuronosyltransferase 1A9 (UGT1A9) suggests the presence of functional UGT1A9 variants. The aim of this study was to evaluate whether the putative functionality of the UGT1A9 variants-118T(9>10) (rs3832043), I399C>T (rs2741049), -275T>A (rs6714486), and-2152C>T (rs17868320) could be confirmed in an independent study. UGT1A9 genotypes and UGT1A9 activity (i.e., flavopiridol and mycophenolic acid glucuronidation) were determined in 46 Caucasian human livers. mRNA levels were quantitated by real-time polymerase chain reaction in 35 of these livers. In addition, samples from 60 unrelated Caucasians belonging to the HapMap Project were also genotyped to confirm the allele frequencies and linkage disequilibrium (LD) pattern observed in our Caucasian livers. The allele frequencies of the-118T(9>10), I399C>T, -275T>A, and-2152C>T variants were 0.39, 0.39, 0.02, and 0.02 in the livers, respectively. The I399C>T variant was in complete LD (r(2) = 1) with-118T(9>10) (linked alleles: C and T(9), respectively). Complete LD between these two variants was also found in the HapMap samples (frequencies of-118T(9>10) and I399C>T = 0.38). I399C>T and-118T(9>10) correlated with neither UGT1A9 activities nor mRNA levels. Because of the low frequencies of the-275T>A and-2152C>T variants, an effect on phenotype could not be evaluated. Our data demonstrate that the common I399C>T and-118T(9>10) polymorphisms do not explain interindividual variation in hepatic UGT1A9 activity and mRNA expression and are in complete LD in the donor liver samples we studied.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761781     DOI: 10.1124/dmd.107.015446

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  14 in total

Review 1.  Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.

Authors:  Jacqueline Ramírez; Mark J Ratain; Federico Innocenti
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

2.  A pharmacogenetic study of vorinostat glucuronidation.

Authors:  Soonmo Peter Kang; Jacqueline Ramirez; Larry House; Wei Zhang; Snezana Mirkov; Wanqing Liu; Eden Haverfield; Mark J Ratain
Journal:  Pharmacogenet Genomics       Date:  2010-10       Impact factor: 2.089

3.  Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.

Authors:  Jacqueline Ramírez; Snezana Mirkov; Larry K House; Mark J Ratain
Journal:  Drug Metab Dispos       Date:  2015-04-13       Impact factor: 3.922

4.  Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia.

Authors:  Irena Loryan; Marja Lindqvist; Inger Johansson; Masahiro Hiratsuka; Ilse van der Heiden; Ron H N van Schaik; Jan Jakobsson; Magnus Ingelman-Sundberg
Journal:  Eur J Clin Pharmacol       Date:  2011-10-18       Impact factor: 2.953

5.  Polymorphic Expression of UGT1A9 is Associated with Variable Acetaminophen Glucuronidation in Neonates: A Population Pharmacokinetic and Pharmacogenetic Study.

Authors:  Matthew W Linakis; Sarah F Cook; Shaun S Kumar; Xiaoxi Liu; Diana G Wilkins; Roger Gaedigk; Andrea Gaedigk; Catherine M T Sherwin; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-10       Impact factor: 6.447

Review 6.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

Review 7.  Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.

Authors:  Mariusz Panczyk
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

8.  Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system.

Authors:  Michael H Court
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

9.  Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver.

Authors:  Wanqing Liu; Jacqueline Ramírez; Eric R Gamazon; Snezana Mirkov; Peixian Chen; Kehua Wu; Chang Sun; Nancy J Cox; Edwin Cook; Soma Das; Mark J Ratain
Journal:  Hum Mol Genet       Date:  2014-05-30       Impact factor: 6.150

10.  Metabolism of megestrol acetate in vitro and the role of oxidative metabolites.

Authors:  Larry House; Michael J Seminerio; Snezana Mirkov; Jacqueline Ramirez; Maxwell Skor; Joseph R Sachleben; Masis Isikbay; Hari Singhal; Geoffrey L Greene; Donald Vander Griend; Suzanne D Conzen; Mark J Ratain
Journal:  Xenobiotica       Date:  2017-11-10       Impact factor: 1.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.